GAIA-BT is an AI-native drug discovery platform that reads, models, and rewrites the molecular logic of disease — from first principles, in silico.
The next generation of medicines will not be found — they will be computed. GAIA-BT is building the engine that makes this true: an integrated model of biology precise enough to design, and fast enough to explore.
Each module feeds the next, collapsing years of sequential discovery into a tight computational cycle that learns with every iteration.
Resolve protein–protein, protein–ligand, and protein–nucleic acid complexes at atomic fidelity — including the interfaces that conventional methods miss.
Generate novel chemistry conditioned on a target, a mechanism, or a disease — not a scaffold. Explore chemical space that has never been synthesised.
Rank, filter, and stress-test candidates in silico against thousands of off-target proteins before a single wet-lab experiment is run.
We partner with biotech and pharmaceutical teams who want to discover like software.
Talk to our team →